There is a phrase William Beacham, MD reaches for when people ask how he ended up an OB-GYN: congenital gynecologist. It was his father’s speciality, too, and his grandfather was a physician. Four of his father’s five brothers also went into medicine. So, by … Read more
Since 2020, Velocity Clinical Research has supported trials that contributed to 61 FDA-approved products — and we couldn’t be more proud of what that represents. Those 61 FDA-approved products span an extraordinary range of therapeutic areas: cardiovascular disease, obesity and diabetes, Alzheimer’s disease, respiratory … Read more
Congratulations to Zydus Therapeutics on the US FDA granting Priority Review to their New Drug Application for saroglitazar for the treatment of Primary Biliary Cholangitis (PBC)! Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG — Velocity Principal Investigator and EPICS-III Study Investigator — was featured … Read more
Given his time again, Robert Buynak, MD, FACP, may well be a train driver — but as a young man, he wasn’t sure how to go about it. Academically gifted, he was raised in the true spirit of the American Dream: “My mom’s family … Read more
Shishir Khetan, MD has always been interested in science and how the body works. His mother was an OB-GYN and, while she never practiced in the U.S., would talk about medicine here and there — a discourse that helped influence his own interest. “My … Read more
Kris Kowdley, MD, AGAF, FAASLD, FACP, FACG, was featured in the recent Mirum Pharmaceuticals announcement that the VISTAS Phase 2b study of volixibat met its primary endpoint in patients with primary sclerosing cholangitis (PSC) and cholestatic pruritus. PSC is a rare, chronic liver disease … Read more
Advarra’s announcement of a new risk‑based AI governance framework features Raghu Punnamraju, CTO of Velocity Clinical Research, underscoring Velocity’s role in advancing responsible AI in clinical trials. Velocity is a founding member of the Council for Responsible Use of AI in Clinical Trials, a … Read more
At Velocity Clinical Research Albuquerque, clinical research is being delivered in a way that reflects the community it serves. Led by Dr. Sara Friedman, a Principal Investigator with a background in OB/GYN, the Albuquerque site is a female-led team focused on women’s health and … Read more
At Velocity in Annapolis, MD, clinical research is delivered as part of everyday healthcare. Located on the Anne Arundel Medical Center campus, the site is embedded within a broader care environment, allowing patients to access clinical trials in the same place they already receive … Read more
Douglas Logan, MD, recently retired from Velocity, but his presence is as big as ever. Talk to our U.S. PIs about their route into research, or their experience at Velocity, and his name is likely to come up. For Matthew Wenker, MD, that story … Read more
For much of her early career, Abbie Youkilis, MD focused on changing healthcare from the outside in. Having begun as a pre-med student at Duke, she pivoted into public policy, earning a master’s degree from Harvard and working in Washington on health policy and … Read more
During this year’s World Vaccine Congress, Velocity Clinical Research will host an exclusive “Dine and Discuss” dinner bringing together a select group of senior leaders from across the vaccine and clinical research ecosystem for an off-the-record conversation with vaccine policy and law expert Richard … Read more
Learn more about Velocity's capabilities
Whether you’re ready to conduct a single-site study or a complex, high-volume trial, Velocity will ensure you have the right investigators, clinical staff, and patients for your research program.
Join a remarkable team doing remarkable work
Velocity careers offer competitive pay and benefits, and reward high performance with excellent opportunities.
Whether you're an industry veteran or are looking to take your first step into clinical research, we invite you to apply at Velocity.